Table 2.
Column A shows the amounts of receptors (Bmax) in membrane preparations from COS-7 and Neuro2A cells after transient transfection with the wt α1D-adrenoceptor (wt), and with the signal peptide-supplemented α1D-adrenoceptor (SP)
Transient expression in COS-7 or Neuro2A cells of wt and signal peptide-supplemented α1D-AR | A. Bmax receptors (fmol mg−1 protein) | B. Bmax receptors (% compared to wt) | C. pKd [3H]-prazosin | n |
---|---|---|---|---|
α1D-AR (wt) COS-7 | 69.3±6.4 | 100 | 9.93±0.10 | 4 |
α1D-AR (SP) COS-7 | 838±200 | 1190±220 | 9.83±0.07 | 4 |
α1D-AR (wt) Neuro2A | 103±31 | 100 | 10.13±0.07 | 4 |
α1D-AR (SP) Neuro2A | 1120±80 | 1300±240 | 9.90±0.09 | 4 |
Column B shows Bmax of the signal peptide-supplemented α1D-AR (SP) in percent of that of the wild type α1D-AR (wt), from experimentally paired plates. Column C shows the pKd values of [3H]-prazosin for the receptors.